LKC Technologies
English
English Español Português 日本
  • Products
    • For Humans
      • RETeval
      • UTAS mf/PERG
      • Sensor Strips
    • For Animals
      • RETevet
      • Request Demo
      • Order Supplies
  • Applications
    • Visual Electrophysiology
      • Electroretinography (ERG)
      • Visual Evoked Potential (VEP)
    • Clinical Conditions
      • Diabetic Retinopathy
      • Glaucoma
      • Retinal Ischemic Diseases
      • Inherited Retinal Disorders
      • Miscellaneous
    • Animal Applications
  • Resources
    • Case Studies
    • eBooks & Reports
    • Webinars
    • Articles
    • Research
    • Blog
    • Videos
    • Software
  • About LKC
    • Vision & Mission
    • Team
    • Clinical Advisors
    • Testimonials
    • History
  • Contact
  • Eye Care Customers
  • VET Customers
  • Buy Sensor Strips

< BACK TO VIDEOS

Improve Glaucoma Management with the RETeval Handheld ERG Device

Transcript

This is Jane. She is 75 years old and suspected to have glaucoma. Her eye pressure is elevated, but the cause could be high blood pressure. However, getting an accurate diagnosis is critical if Jane wants to avoid vision loss or even blindness. Sadly, getting an accurate diagnosis is not easy. It is a process that can require several rounds of tests before Jane’s doctor can recommend a course of action.

Unfortunately, Jane also suffers from cataracts, which impair image quality and make a reliable diagnosis difficult. An additional perimetry test for functional deficits produces borderline results, suggesting a possible deficit. But it is unclear whether this deficit is real, or whether Jane was tired or distracted during the test. To be sure, an additional test option is the full-field flash electroretinogram, or ERG.

An ERG uses light to assess the function of photoreceptor, bipolar, and ganglion cells in the eye. In particular, it measures what’s known as the photopic negative response. This response is specific to ganglion cells and can reflect the presence and severity of glaucoma. Historically, the test procedure has been lengthy and difficult to perform. That, combined with inconsistent results between tests, has limited the clinical use of ERG.

But with the RETeval® system, ERG has significantly improved. The RETeval handheld device uses skin electrodes, needs no dilation, and provides color-coded test results to comfortably evaluate ERG results. To address test–retest variability, the RETeval team has recently developed a new algorithm that offers better test-retest variability to objectively detect and monitor glaucoma patients.

With little effort, Jane’s RETeval measurements are done, and they suggest some abnormalities. Based on these additional findings, Jane receives a more objective diagnosis, appropriate medication, and a more informed follow-up. On her follow-up visit, Jane undergoes another ERG.

Research has shown that over time, ERGs can reveal subtle changes after starting medicine to reduce intraocular eye pressure, even if no other biomarker indicates improvement.

Making ERG a part of glaucoma management offers valuable information to the treatment decision process, even when media opacities are present. And with new developments, ERG looks to become an increasingly relevant and useful tool in the challenging process of diagnosing glaucoma.

  • Products
    • RETeval
    • UTAS mf/PERG
    • Sensor Strips
    • RETevet
  • Electrophysiology Tests
    • Electroretinography (ERG)
    • Full-Field ERG (ffERG)
    • Pattern ERG (PERG)
    • Multifocal ERG (mfERG)
    • Visual Evoked Potential (VEP)
    • Address2 Professional Drive, Suite 222
      Gaithersburg, MD 20879 USA
    • Phone+1 301 840 1992 (US & Canada)
      +358 40 8486625 (International)
    • International Distributors
      • Medical Device Distributors
      • Veterinary Device Distributors
  • Follow LKC Technologies on LinkedIn
  • Follow LKC Technologies on Facebook
  • Subscribe to LKC Technologies on YouTube
  • Follow LKC Technologies on Instagram
cropped-cropped-LKC_logo_RGB_color_no_tagline_mini_400px.png
© 2025 LKC Technologies, Inc.
  • Accessibility Statement
  • Terms & Conditions
  • Certifications
  • Privacy Policy
  • Careers

California Proposition 65 information

Prop-65Warning: This product can expose you to chemicals including lead, which is known to the State of California to cause cancer and birth defects or other reproductive harm. For more information go to www.P65Warnings.ca.gov.

Substance Tables:

The table below lists substances which may be contained within LKC’s RETeval and RETevet products. Substances listed as Type 1 are within permissible levels in one or more of LKC’s products. Substances listed as Type 2 are used in the production of some components used in LKC products and may be present at trace levels, but are typically destroyed during processing. 

RETeval and RETevet Devices

Substance CAS # Type Listed as causing:
Nickel 7440-02-0 1 Cancer
Acrylonitrile 107-13-1 2
Ethylbenzine 100-41-4 2
Crystaline Silica 14808-60-7 1
Lead 7439-92-1 1 Cancer Developmental Toxicity Male Reproductive Toxicity Female Reproductive Toxicity
Methylene Chloride 75-09-2 2 Cancer Female Reproductive Toxicity
Bisphenol A 80-05-7 2
N-Hexane  110-54-3 2 Male Reproductive Toxicity